R50.84
Febrile nonhemolytic transfusion reaction
Clinical Classification Guidelines
Inclusion Terms
- FNHTR
- Posttransfusion fever
Medical Intelligence & Overview
Febrile nonhemolytic transfusion reaction (FNHTR) is a common side effect that can occur after a blood transfusion. It is characterized by a fever that develops during or shortly after the transfusion process. While it can be uncomfortable and alarming, FNHTR is usually not serious and can be managed effectively. Recognizing its symptoms and understanding its causes can help patients and healthcare providers manage this reaction appropriately.
Causes & Symptoms
Clinical Causes: Immune response to donor white blood cells Presence of cytokines released during blood storage Incompatibility between donor and recipient blood components Reactions to medications or other substances in transfused blood
Key Symptoms: Fever, typically a rise of 1°C (1.8°F) or more from the pre-transfusion temperature Chills or shivering Headache Mild fatigue or malaise Back pain in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of FNHTR is primarily based on the clinical presentation and timing. Healthcare providers will monitor the patient's temperature during and after the transfusion and review medical history for prior reactions. Blood tests may be performed to rule out other causes of fever, such as infection. It's important to document the reaction thoroughly to guide future transfusions and management strategies.
Treatment Protocols: Stopping the transfusion temporarily or permanently if reactions recur Administering antipyretic medications like acetaminophen to reduce fever Monitoring vital signs regularly Providing fluids to maintain hydration In some cases, premedication with antipyretics or antihistamines might be recommended before future transfusions Educating the patient about recognizing symptoms and reporting any future reactions
Clinical Advice & FAQs
Billing Guidance
Is R50.84 a billable ICD-10 code?
Yes, R50.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R50.84?
Clinical documentation must specify the nature of Febrile nonhemolytic transfusion reaction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference